Concepedia

Will Jiang

WJ

Statistics

Publications

5

Citations

165

H-Index

5

Active since

2022

Affiliations

Kelowna General Hospital(Current)

University of British Columbia

Positive Living North

University of British Columbia, Okanagan Campus

University of Victoria

Will Jiang is an author at Kelowna General Hospital specializing in oncology, oligometastatic disease treatment, and medicine.

Publications per year

2022–2024

5

Publications

5

Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer

Robert Olson, Will Jiang, Mitchell Liu et al. · JAMA Oncology · 2022 · 69 citations · Full text

, , +13

Progression-Free Survival and Local Control After SABR for up to 5 Oligometastases: An Analysis From the Population-Based Phase 2 SABR-5 Trial

Sarah Baker, Will Jiang, Benjamin Mou et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 43 citations

, , +5

Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial

Reno Eufemon Cereno, Benjamin Mou, Sarah Baker et al. · Radiotherapy and Oncology · 2023 · 28 citations

, , +17

Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial

Sarah Baker, Linden Lechner, Mitchell Liu et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · 15 citations

, , +6

Predictors of Early Polymetastatic Relapse After SABR for up to 5 Oligometastases: A Secondary Analysis of the Phase II SABR-5 Trial

Sarah Baker, Benjamin Mou, Will Jiang et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 10 citations

, , +6

1–5 of 5